Atlas Trials

Pharmacologic Augmentation of Targeted Cognitive Training in Schizophrenia

Clinical trial NCT04414930 · COMPLETED

Trial details

NCT number
NCT04414930
Sponsor
University of California, San Diego
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
SchizophreniaSchizoaffective Disorder
Start date
2020-11-09
Primary completion
2024-12-30
Enrollment
68

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.